Who owns the PHLARE PRECISE HLA REDIRECTING ENGAGERS trademark?

The PHLARE PRECISE HLA REDIRECTING ENGAGERS trademark is owned by Clasp Therapeutics, Inc..

What class is the PHLARE PRECISE HLA REDIRECTING ENGAGERS trademark registered in?

The PHLARE PRECISE HLA REDIRECTING ENGAGERS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

What is the serial number for PHLARE PRECISE HLA REDIRECTING ENGAGERS?

The USPTO serial number for PHLARE PRECISE HLA REDIRECTING ENGAGERS is 98611242.

What is the registration number for PHLARE PRECISE HLA REDIRECTING ENGAGERS?

PHLARE PRECISE HLA REDIRECTING ENGAGERS is registered under USPTO registration number 0.

PHL

USPTO Trademark Record

PENDING

PHLARE PRECISE HLA REDIRECTING ENGAGERS

SN 98611242·Reg 0·Filed Jun 20, 2024

Owner Clasp Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

PHLARE PRECISE HLA REDIRECTING ENGAGERS (Serial No. 98611242), Registration No. 0, is a pending US trademark filed on Jun 20, 2024 by Clasp Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Statement of Use due: September 30, 20261 days remaining

Mark Intelligence

PHLARE PRECISE HLA REDIRECTING ENGAGERS (Reg. #0) is a pending US trademark that was filed in 2024 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 20, 2024

SERIAL

98611242

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Clasp Therapeutics, Inc.

Entity

Corporation

State

Address

1450 Research Boulevard, Suite 120, Rockville, MD, 20850

Country

Attorney

NameScott M. Sisun, Esq.

Law firm

Scott M. Sisun, Esq. Sisun Law

Address

135 Madison Avenue, Floor 5, New York, NY 10016, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateJun 20, 2024

Serial Number98611242

Registration No.0

Registration DateDec 31, 1969

Status DateNov 06, 2025

Published for OppositionJun 10, 2025

Mark TypeDesign with words

Status DescriptionLive and pending, first extension granted

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 07, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 06, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Nov 06, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Nov 06, 2025

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 30, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 10, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 10, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 04, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 08, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 14, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 14, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 14, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 12, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 12, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 12, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ASSIGNED TO EXAMINER

Jan 14, 2025

ASSIGNED TO EXAMINER

PRIORITY ACTION WRITTEN

Jan 14, 2025

PRIORITY ACTION WRITTEN

PRIORITY ACTION E-MAILED

Jan 14, 2025

PRIORITY ACTION E-MAILED

NOTIFICATION OF PRIORITY ACTION E-MAILED

Jan 14, 2025

NOTIFICATION OF PRIORITY ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 13, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 20, 2024

NEW APPLICATION ENTERED

PHLARE PRECISE HLA REDIRECTING ENGAGERS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Clasp Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Scott M. Sisun, Esq.

Resources

Company